Key Highlights of the Veterinary Molecular Diagnostics Market 2025-2034: Growth Dynamics, Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Projected Compound Annual Growth Rate (CAGR) of the Veterinary Molecular Diagnostics Market from 2025 to 2034, and What Factors Influence It?
In recent times, the veterinary molecular diagnostics market has been expanding swiftly. It is projected to increase from $0.63 billion in 2024 to $0.7 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. The historic trend of growth is largely due to the widespread occurrence of zoonotic and foodborne diseases, the increase in adoption of multiple diagnostic tests, the growing consolidation in the veterinary diagnostic sector, an increase in animal health expenditure, and the escalating demand for food obtained from animals.
The market for veterinary molecular diagnostics is anticipated to witness considerable expansion in the coming years, surging to a worth of $1.01 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this projected growth include a surge in the ownership of pets, an increase in the uptake of pet insurance, a growing pet population, a rise in spending on animal health care, and heightened need for animal diagnostic tests. The anticipated trends during this forecast period encompass advancements in veterinary molecular diagnostic technologies, state-of-the-art laboratory devices, and enhanced technology such as Polymerase Chain Reaction (PCR), next-generation sequencing (NGS), and microarray technological advancements.
What Combination of Drivers Is Leading to Accelerated Growth in the Veterinary Molecular Diagnostics Market?
The veterinary molecular diagnostics market’s expansion is anticipated to be fueled by the high occurrence of zoonotic diseases. Zoonotic diseases, which are infections transmitted between animals and humans, can be caused by bacteria, viruses, parasites, or fungi. Some commonly known zoonotic diseases are rabies, Lyme disease, salmonellosis, and toxoplasmosis. Factors like deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility influence the prevalence of these diseases. Through early detection of zoonotic diseases in animals, veterinary molecular diagnostics can effectively prevent their transmission to humans. Moreover, they facilitate disease control by allowing swift and precise identification of pathogens. For example, a report released by the UK Government in February 2024 indicated that there were 335 confirmed cases of Lyme disease in England during the fourth quarter of 2023, up from 273 in the corresponding period in 2022. Consequently, the escalating occurrence of zoonotic diseases is propelling the growth of the veterinary molecular diagnostics market.
Explore Comprehensive Insights Into The Global Veterinary Molecular Diagnostics Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp
Who Are the Leading Players Fueling Growth in the Veterinary Molecular Diagnostics Market?
Major companies operating in the veterinary molecular diagnostics market are:
• Roche Diagnostics Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Zoetis Inc.
• Illumina Inc.
What Are the Emerging Trends Shaping the Future of the Veterinary Molecular Diagnostics Market?
Leading firms in the veterinary molecular diagnostics market are prioritizing automation and scalability in diagnostic technologies, including high-volume testing devices. These advancements are aimed at enhancing diagnostic precision, boosting testing efficiency, and facilitating prompt disease identification in animals. High-volume testing machines, developed diagnostic tools capable of handling substantial amounts of samples effectively, are especially suitable for large-scale testing due to their speedy and accurate laboratory or clinical analysis. For example, the Veterinary Diagnostic Laboratory (VDL) from the US-based Iowa State University, launched SmartChip in June 2023. It is a state-of-the-art molecular diagnostic test device featuring quantitative polymerase chain reaction (qPCR) testing technology. This groundbreaking device can hold more than 5,000 samples on a plate no larger than a postage stamp and increases its testing capacity manifold when combined with a system capable of handling 384 samples automatically. The SmartChip test uses microfluidic technology to detect targets of interest in samples using a volume that’s 100 times smaller than what is used in VDL’s traditional 96-well machines.
Get Instant Access to the Global Veterinary Molecular Diagnostics Market Report with Swift Delivery!
Which Segments Play a Crucial Role in the Expansion of the Veterinary Molecular Diagnostics Market?
The veterinary molecular diagnostics market covered in this report is segmented –
1) By Product: Kits And Reagents, Instrument
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Infectious Diseases, Genetic Diseases, Other Applications
4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
Subsegments:
1) Kits and Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents for Next-Generation Sequencing (NGS)
2) Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems
Which Regions Are Driving Growth in the Veterinary Molecular Diagnostics Market?
North America was the largest region in the Veterinary Molecular Diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Features of the Veterinary Molecular Diagnostics Market?
Veterinary molecular diagnostics refers to using molecular biology techniques to identify and diagnose animal diseases at a genetic or molecular level. These tests detect the presence of specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that indicate disease, helping veterinarians make accurate diagnoses and treatment plans.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Diagnostic Equipment Global Market Report 2025
Veterinary Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Veterinary Parasiticides Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
